A collaboration to produce superior heartbeat biometric and health monitoring capabilities for wearables has been agreed to by B-Secur and LifeQ.
B-Secur’s Electrocardiogram (EKG/ECG) technology will be integrated with LifeQ’s optical PPG (photoplethysmography) technology to enable advanced identification, wellness and health monitoring features in the next generation of everyday devices, according to the announcement. The companies say in the press release that each is widely recognized for best-in-class performance for their respective technologies.
Many wearables utilize PPG for blood flow monitoring, and LifeQ provides PPG signal conditioning to leading consumer technology companies for higher accuracy in business and clinical applications. B-Secur says advances in ECG technology can enable high-accuracy biosensing in future product releases.
“Many of the technology features that are on offer through an integrated B-Secur and LifeQ solution are currently only accessible in medical environments or by the fortunate few. Today’s announcement will accelerate access of this type of information to everyone. We are very fortunate to find a partner in LifeQ that shares a common goal and we are confident that together we provide class-beating technologies,” states Alan Foreman, CEO of B-Secur.
The collaboration is expected to speed up the integration, launch and adoption of high-performance biosensing solutions OEMs for secure health and wellness features in smartwatches and other fitness trackers.
“With technology advancement and the increasing quest to improve health and wellbeing, whether to consumers, employees, employers, and even governments, the global biosensing market has grown exponentially in recent years,” says Laurie Olivier, CEO of LifeQ. “Events such as COVID-19 have further highlighted the importance of real time health monitoring and, specifically to make this available to everyone. We are thrilled that our partnership with B-Secur allows us to accelerate our goal of improving wellbeing and reducing the cost of good health for all in conjunction with some of the world’s leading technology companies.”